Figure 1From: Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer Survival curves of adjuvant goserelin and adjuvant chemotherapy for premenopausal breast cancer patients.Back to article page